Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer
Frederik Birkebaek Thomsen, Ib Jarle Christensen, Klaus Brasso,
Martin Andreas Røder
, Peter Iversen
Department of Clinical Medicine
Section of Biostatistics
13
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Prostate-specific antigen doubling time as a progression criterion in an active surveillance programme for patients with localized prostate cancer'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Progression Criteria
100%
Active Surveillance
100%
Localized Prostate Cancer
100%
Prostate-specific Antigen Doubling Time
100%
Confidence Interval
50%
Prostate-specific Antigen
50%
Risk of Progression
25%
Radical Prostatectomy
25%
Low-risk Prostate Cancer
12%
Clinical Progression
12%
Patient Management
12%
Patient-centered
12%
Value of Time
12%
Misclassified
12%
High Risk
12%
Risk Treatment
12%
Intermediate-risk Group
12%
Definitive Treatment
12%
Consecutive Patients
12%
Treatment Options
12%
High-risk Population
12%
Significant Risk Factors
12%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Specific Antigen
100%
Prostate Cancer
100%
Immunology and Microbiology
Prostate Specific Antigen
100%
High Risk Population
50%
Intermediate Risk Population
16%